LP(A) LIPOPROTEIN, IGG, IGA AND IGM ANTIBODIES TO CHLAMYDIA-PNEUMONIAE AND HLA CLASS-II GENOTYPE IN EARLY CORONARY-ARTERY DISEASE

被引:101
|
作者
DAHLEN, GH
BOMAN, J
BIRGANDER, LS
LINDBLOM, B
机构
[1] UMEA UNIV HOSP,DEPT CLIN VIROL,S-90185 UMEA,SWEDEN
[2] UMEA UNIV HOSP,DEPT MED,S-90185 UMEA,SWEDEN
[3] LINKOPING UNIV HOSP,STATE INST FORENS SEROL,S-58185 LINKOPING,SWEDEN
关键词
LP(A) LIPOPROTEIN; CHLAMYDIA PNEUMONIAE; HLA ANTIGENS; CYTOKINES; CORONARY HEART DISEASE; AUTOIMMUNE DISORDERS;
D O I
10.1016/0021-9150(94)05480-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The associations previously found between lipoprotein(a) (Lp(a)) levels and atherosclerotic disorders, diabetes, rheumatoid arthritis and renal diseases suggest that Lp(a) may be involved in autoimmune reactions. The relation found between Lp(a) levels and the HLA class II genotype in males with early coronary artery disease (CAD) further support that assumption. It was suggested that an autoimmune process, perhaps triggered by a concomitant intracellular infection may occur especially in patients with inherited high Lp(a) levels in combination with certain inherited HLA class II genotypes. In this study a Chlamydia pneumoniae IgG titer greater than or equal to 32 was significantly more common (P = 0.036) in CAD patients than in matched controls. This is in agreement with previous reports by other investigators. In addition, an IgG titer greater than or equal to 256 in combination with an Lp(a) level greater than or equal to 120 mg/l was found to occur significantly more often (P = 0.011) in male patients than in male controls. Certain HLA class II DR genotypes in combination with high Lp(a) levels and C. pneumoniae titers occurred more frequently in both male and female patients than in controls. Some combinations were very common in male patients, and the difference in comparison with male controls was highly significant.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 8 条
  • [1] LP(A) LIPOPROTEIN AND HLA-DR GENOTYPE IN EARLY CORONARY-ARTERY DISEASE
    DAHLEN, GH
    SLUNGA, L
    HOLMLUND, G
    LANGO, A
    LINDBLOM, B
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 1993, 20 (02): : 95 - 102
  • [2] SMOKING IS A POTENTIAL CONFOUNDER OF THE CHLAMYDIA-PNEUMONIAE - CORONARY-ARTERY DISEASE ASSOCIATION
    HAHN, DL
    GOLUBJATNIKOV, R
    ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (08): : 945 - 947
  • [3] CHLAMYDIA-PNEUMONIAE STRAIN TWAR ANTIBODY AND ANGIOGRAPHICALLY DEMONSTRATED CORONARY-ARTERY DISEASE
    THOM, DH
    WANG, SP
    GRAYSTON, JT
    SISCOVICK, DS
    STEWART, DK
    KRONMAL, RA
    WEISS, NS
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03): : 547 - 551
  • [4] ASSOCIATION OF PRIOR INFECTION WITH CHLAMYDIA-PNEUMONIAE AND ANGIOGRAPHICALLY DEMONSTRATED CORONARY-ARTERY DISEASE
    THOM, DH
    GRAYSTON, JT
    SISCOVICK, DS
    WANG, SP
    WEISS, NS
    DALING, JR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (01): : 68 - 72
  • [5] THE ASSOCIATION BETWEEN CHLAMYDIA-PNEUMONIAE STRAIN TWAR ANTIBODY AND ANGIOGRAPHICALLY DEMONSTRATED CORONARY-ARTERY DISEASE
    THOM, DH
    WANG, SP
    GRAYSTON, JT
    SISCOVICK, DS
    STEWART, DK
    WEISS, NS
    KRONMAL, RA
    CIRCULATION, 1991, 83 (02) : 736 - 736
  • [6] Cytokine and integrin profiles and IgG and IgA seropositivity to Chlamydia pneumoniae in patients with stable coronary artery disease
    Drobniak-Heldak, Dominika
    Kolasinska-Kloch, Wladyslawa
    Rajtar, Renata
    Kloch, Malgorzata
    Kiec-Wilk, Beata
    Furgala, Agata
    Dembinska-Kiec, Aldona
    ACTA CARDIOLOGICA, 2007, 62 (06) : 628 - 629
  • [7] Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies -: Are they risk factors or serologic predictors for progression of coronary artery disease?
    Tontsch, D
    Noll, B
    Schaefer, JR
    Herzum, M
    Maisch, B
    Goeke, B
    ANGIOLOGY, 2000, 51 (10) : 831 - 836
  • [8] IgM to IgG Anti-HLA class II antibody switching in cardiac transplant recipients is associated with increased risk of cellular rejection and coronary artery disease and is prevented by mycophenolic acid
    Lietz, K
    Burke, E
    Tung, T
    Baran, DA
    Ankersmit, J
    Mancini, D
    Suciu-Foca, N
    Edwards, NM
    Itescu, S
    CIRCULATION, 1999, 100 (18) : 525 - 526